There are currently many new and emerging therapies treating inflammatory bowel disease.

In a virtual presentation for the Interdisciplinary Autoimmune Summit, Stephen B. Hanauer, MD, professor of Medicine at Northwestern University in Chicago, said gastroenterologists need to begin to use biologic agents that are more highly effective overall.

Hanauer also said there are potential considerations to evaluate when choosing the best treatment for patients with IBD, such as how quickly a patient needs to get back to remission, early signs of nonresponse to treatment, individual preference based on

Full Article: https://www.healio.com/news/gastroenterology/20200713/emerging-therapies-for-ibd-finding-longterm-treatment-without-steroids